Streetbeat News

ARAV

Aravive Inc

https://aravive.com/

CEO

Gail McIntyre

Employees

40

Industry

Pharmaceutical Preparation Manufacturing

versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.

Open

0.04

Mkt cap

2.9M

Volume

4M

High

0.05

P/E Ratio

-0.05

52-wk high

2.46

Low

0.04

Div yield

N/A

52-wk low

0.04

In Friday's pre-market session, several healthcare stocks experienced significant movements. Inspire Veterinary (IVP) saw a 178.9% increase, Aclarion (ACON) rose by 115.01%, and Panbela Therapeutics (PBLA) went up by 61.23%. Conversely, Onconetix (ONCO) dropped by 32.8%, Jin Medical International (ZJYL) fell by 18.52%, and Passage Bio (PASG) declined by 11.09%. Other notable movements included gains for Corbus Pharmaceuticals (CRBP), NeuBase Therapeutics (NBSE), and Ainos (AIMD), and losses for PTC Therapeutics (PTCT), Aravive (ARAV), and Sagimet Biosciences (SGMT).

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 1:06 pm

In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Ensysce Biosciences (ENSC), Outlook Therapeutics (OTLK), INVO Bioscience (INVO), Kronos Bio (KRON), vTv Therapeutics (VTVT), and Pluri (PLUR) saw their shares rise by 11.03% to 28.1%. Conversely, Inovio Pharmaceuticals (INO), Venus Concept (VERO), Panbela Therapeutics (PBLA), Aclarion (ACON), Renalytix (RNLX), and Aravive (ARAV) witnessed declines ranging from 11.76% to 20.5%.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 1:06 pm

United Airlines Holdings, Inc. (NASDAQ:UAL) shares rose by 6% in pre-market trading after reporting Q4 earnings of $2.00 per share, beating estimates of $1.70, and sales of $13.60 billion, above the expected $13.54 billion. However, the company anticipates a wider-than-expected loss for Q1. Other stocks also moved in pre-market trading, with notable gainers including vTv Therapeutics Inc. (VTVT) and losers such as Vroom, Inc. (VRM), which is discontinuing its ecommerce operations.

Portfolio Pulse from Avi Kapoor

January 23, 2024 | 12:55 pm

U.S. stocks traded higher, with the Dow Jones gaining over 100 points. M&T Bank Corporation (NYSE:MTB) reported Q4 earnings below expectations at $2.81 per share against estimates of $3.49 per share, though sales slightly exceeded expectations. Agrify Corporation (NASDAQ:AGFY) surged 18% after announcing a sales agreement. M.D.C. Holdings, Inc. (NYSE:MDC) jumped 18% due to acquisition news by Sekisui House. LiveRamp Holdings, Inc. (NYSE:RAMP) gained 9% after announcing an acquisition and preliminary revenue results. Aravive, Inc. (NASDAQ:ARAV), Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), and eHealth, Inc. (NASDAQ:EHTH) saw significant stock declines.

Portfolio Pulse from Avi Kapoor

January 18, 2024 | 7:25 pm

KeyCorp (NYSE:KEY) shares dropped by 5.4% to $13.10 after reporting Q4 financial results with revenues of $1.538 billion, down 19% Y/Y, but slightly above consensus. Adjusted EPS of 25 cents also exceeded expectations. Other stocks experienced significant movements in Thursday's mid-day session, with various companies reporting gains due to different reasons such as acquisitions, financial results, and analyst upgrades. Conversely, several companies saw their shares fall due to negative news such as voluntary delisting, reverse stock splits, and disappointing earnings guidance.

Portfolio Pulse from Avi Kapoor

January 18, 2024 | 6:08 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. Celularity (CELU) saw a 44.7% increase, while NovoCure (NVCR) rose by 24.15%. Jasper Therapeutics (JSPR) and Nuvectis Pharma (NVCT) also saw upward movements of 22.18% and 14.85%, respectively. Bullfrog AI Hldgs (BFRG) and Venus Concept (VERO) stocks rose by 14.74% and 14.28%. On the downside, Aravive (ARAV) dropped by 43.2%, Processa Pharma (PCSA) by 26.35%, and ZyVersa Therapeutics (ZVSA), 60 Degrees (SXTP), Cano Health (CANO), and MAIA Biotechnology (MAIA) also experienced declines.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 5:31 pm

U.S. stocks were mostly higher with the Nasdaq Composite up over 1%. The Dow was slightly down, while the S&P 500 gained. Information technology shares led gains, while health care shares declined. Crude oil inventories decreased more than expected, boosting oil prices. Agrify Corporation announced a significant sales agreement, M.D.C. Holdings will be acquired by Sekisui House, and Taiwan Semiconductor reported strong financial results. Conversely, Aravive plans to delist from Nasdaq, Processa Pharmaceuticals announced a reverse stock split, and eHealth was downgraded by an analyst.

Portfolio Pulse from Avi Kapoor

January 18, 2024 | 5:00 pm

Aravive, Inc. has announced its decision to delist from the Nasdaq, leading to a decline in its stock price. This move may affect investor confidence and the stock's liquidity, as it will no longer be traded on a major exchange.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 3:28 pm

U.S. stocks traded mixed with the Nasdaq Composite rising over 100 points. The Dow fell 0.33%, while the S&P 500 gained 0.43%. U.S. initial jobless claims dropped to 187,000, below market estimates of 207,000. Information technology shares led gains, while health care shares declined. Agrify Corporation (AGFY) surged 133% after announcing a new facility in California. Lytus Technologies (LYT) and Celularity Inc. (CELU) also saw significant gains. Aravive, Inc. (ARAV), Processa Pharmaceuticals (PCSA), and Newcourt Acquisition Corp (NCAC) experienced notable declines.

Portfolio Pulse from Avi Kapoor

January 18, 2024 | 2:47 pm

In Thursday's pre-market session, several healthcare stocks experienced significant movements. Celularity (CELU) saw a 43.4% increase, while Kronos Bio (KRON) rose by 33.64%. Jin Medical International (ZJYL) and Telesis Bio (TBIO) also saw substantial gains. Conversely, Aravive (ARAV) dropped by 50.5%, AtriCure (ATRC) by 34.16%, and Humana (HUM) by 14.24%, among other decliners.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 1:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.